Effect of candesartan on recurrence of esophageal varices after endoscopic therapy with hypertenton

Effect of candesartan on recurrence of esophageal varices after endoscopic therapy with hypertenton - Effect of candesartan on recurrence of esophageal varices after endoscopic therapy with hypertenton

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002088

Enrollment

Registered

2009-06-17

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal varices

Interventions

Administration of candesartan for esophageal varices Administration of carcium blocker for esophageal varices

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will undergo endoscopic therapy for wsophageal varices with hypertention

Exclusion criteria

Exclusion criteria: Patients who take beta-blocker, nitrates or angiotensin receptor antagonist

Design outcomes

Primary

Measure	Time frame
ratio of rcurrence of esophageal veaces and bleeding	—

Countries

Japan

Contacts

Public ContactHiroyuki Imaeda, M.D., Ph.D.

Keio University Division of Gastroenterology,Department of Internal Medicine

03-5363-3600

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026